NCT03846258View on ClinicalTrials.gov

High Versus Low Bicarbonate Bath in Critically-ill Patients Receiving Continuous Renal Replacement Therapy

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 1, 2019

Primary Completion Date

April 1, 2024

Study Completion Date

April 1, 2024

Conditions
Metabolic AcidosisAcute Kidney InjuryAcute Kidney Failure
Interventions
DRUG

Low bicarbonate solution (22 mmol/L)

Participants randomized to this arm will be started on CRRT using Phoxillum as the replacement fluid.

DRUG

High Bicarbonate solution (32 mmol/L)

Participants randomized to this arm will be started on CRRT using Prismasate as the replacement fluid.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03846258 - High Versus Low Bicarbonate Bath in Critically-ill Patients Receiving Continuous Renal Replacement Therapy | Biotech Hunter | Biotech Hunter